Medicare billing address
CMS Medicare provider billing file
224 W. Exchange St.Suite 380
Akron, OH 44302
CMS public data · NPI 1760645428
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Joseph E Khabbaza, M.D.
Specialty
Credential
M.D.
NPI
1760645428
Primary source state
OH
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Joseph E Khabbaza, M.D. from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
224 W. Exchange St.CMS Doctors & Clinicians file
12300 Mccracken RdCMS Doctors & Clinicians file
14601 Detroit AveCMS Doctors & Clinicians file
17840 Bagley RdIn the 2024 CMS provider billing file, this NPI had 2,798 Medicare beneficiaries and 5,433 total services. The average beneficiary age was 73, and the average HCC risk score was 2.
Total Medicare allowed amount
$129,956.18
Total Medicare payment amount
$97,820.38
Medicare beneficiaries
2,798
Total services
5,433
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
75%
CMS beneficiary-panel share
COPD
49%
CMS beneficiary-panel share
Ischemic heart disease
44%
CMS beneficiary-panel share
Chronic kidney disease
36%
CMS beneficiary-panel share
Heart failure
36%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Test to measure expiratory airflow and volume | 1,097 | $7.65 |
| Test for exercise-induced lung stress | 860 | $20.64 |
| Test to examine how well the lungs exchange gases | 833 | $8.29 |
| Test to measure expiratory airflow and volume | 482 | $7.64 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 390 | $9.62 |
| Test to examine how well the lungs exchange gases | 384 | $8.31 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 303 | $9.59 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 198 | $96.78 |
| Test for exercise-induced lung stress | 130 | $20.65 |
| Critical care, first 30-74 minutes | 117 | $199.77 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1760645428. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Azithromycin | Azithromycin | 204 | 267.8 | $3,252.88 |
| 2 | Albuterol Sulfate Hfa | Albuterol Sulfate | 203 | 243 | $5,541.29 |
| 3 | Prednisone | Prednisone | 125 | 151.1 | $611.00 |
| 4 | Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 104 | 125 | $57,250.18 |
| 5 | Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 87 | 97.5 | $58,663.56 |
| 6 | Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 63 | 71 | $11,115.85 |
| 7 | Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 62 | 74 | $46,514.25 |
| 8 | Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 48 | 68 | $7,426.92 |
| 9 | Bevespi Aerosphere | Glycopyrrolate/Formoterol Fum | 46 | 60 | $24,456.83 |
| 10 | Symbicort | Budesonide/Formoterol Fumarate | 46 | 85 | $17,660.77 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
State University Of Ny Upstate Medical University
Graduation year
2008
Group/practice field
Cleveland Clinic
Telehealth reported
Yes
Secondary specialty fields reported by CMS: Pulmonary Disease.
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.